HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
122,604,908
Share change
+12,044,201
Total reported value
$2,104,656,029
Put/Call ratio
18%
Price per share
$17.18
Number of holders
199
Value change
+$207,889,231
Number of buys
105
Number of sells
79

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2019

As of 30 Jun 2019, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,604,908 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Third Security, LLC, Bellevue Group AG, Invesco Ltd., IRIDIAN ASSET MANAGEMENT LLC/CT, JPMORGAN CHASE & CO, STATE STREET CORP, Thrivent Financial for Lutherans, and PICTET ASSET MANAGEMENT LTD. This page lists 199 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
198
Q2 2019 holders
199
Holder diff
1
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.